SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
U.S. President Donald Trump signs the Executive Order Promoting Agriculture and Rural Prosperity in America as Agriculture Secretary Sonny Perdue looks on during a roundtable with farmers in the Roosevelt Room of the White House on April 25, 2017 in Washington, D.C. (Photo: Olivier Douliery-Pool/Getty Images)
Alarm Sounded Over Trump's 'Little Noticed' Push to Undermine Food Safety
"There has been no dialogue on this proposal with the broad food safety community and no explanation from USDA of the problem the proposed reorganization solves."
Oct 02, 2017
In what critics are describing as a move to prioritize exports over public health, the Trump administration is quietly planning to transfer work on international food safety standards from the U.S. Department of Agriculture's (USDA) health arm to its brand new trade arm, which is supervised by former animal-drug industry executive Ted McKinney.
"There has been no dialogue on this proposal with the broad food safety community and no explanation from USDA of the problem the proposed reorganization solves."
--Michael Taylor, former FDA officialPolitico's Helena Bottemiller Evich first reported the "little-noticed" plan on Monday. Much of the concern "involves the USDA's staff that manages the U.S.' participation in the Codex Alimentarius Commission, a little-known but powerful standards-setting panel that sits under the U.N. Food and Agriculture Organization and the World Health Organization and is crucial for resolving trade disputes under the WTO," Bottemiller Evich notes.
The Codex Commission is currently debating whether to impose residue limits on the controversial drug zilpaterol, marketed as "beef-improvement technology" that is primarily used to promote growth in cattle.
Michael Hansen, a senior scientist at Consumers Union, told Politico that the Trump administration's decision to place McKinney--former global corporate affairs director of the animal pharmaceutical giant Elanco--in charge of what is often called "the food code" raises serious questions about "whether the U.S. will put even more pressure to make sure zilpaterol gets through."
The European Union, China, and other nations have insisted that zilpaterol--as well as ractopamine, a drug that promotes leanness and muscle growth in animals--is not safe for human or animal consumption and should not be used in food production. The U.S. approved the drug despite these concerns.
While representatives of the food industry were quick to praise the Trump administration's decision to place the Codex office under the watch of a former corporate executive, Michael Taylor, former deputy commissioner for foods at the Food and Drug Administration under former President Barack Obama, argued that the move had been undertaken with virtually no debate or discussion and that it "threatens the scientific credibility of the United States in Codex proceedings."
"There has been no dialogue on this proposal with the broad food safety community and no explanation from USDA of the problem the proposed reorganization solves," Taylor said.
The Trump administration's decision, Taylor concluded, could ultimately lower food safety standards, which would lead to "significant negative consequences in Africa and other developing regions."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
In what critics are describing as a move to prioritize exports over public health, the Trump administration is quietly planning to transfer work on international food safety standards from the U.S. Department of Agriculture's (USDA) health arm to its brand new trade arm, which is supervised by former animal-drug industry executive Ted McKinney.
"There has been no dialogue on this proposal with the broad food safety community and no explanation from USDA of the problem the proposed reorganization solves."
--Michael Taylor, former FDA officialPolitico's Helena Bottemiller Evich first reported the "little-noticed" plan on Monday. Much of the concern "involves the USDA's staff that manages the U.S.' participation in the Codex Alimentarius Commission, a little-known but powerful standards-setting panel that sits under the U.N. Food and Agriculture Organization and the World Health Organization and is crucial for resolving trade disputes under the WTO," Bottemiller Evich notes.
The Codex Commission is currently debating whether to impose residue limits on the controversial drug zilpaterol, marketed as "beef-improvement technology" that is primarily used to promote growth in cattle.
Michael Hansen, a senior scientist at Consumers Union, told Politico that the Trump administration's decision to place McKinney--former global corporate affairs director of the animal pharmaceutical giant Elanco--in charge of what is often called "the food code" raises serious questions about "whether the U.S. will put even more pressure to make sure zilpaterol gets through."
The European Union, China, and other nations have insisted that zilpaterol--as well as ractopamine, a drug that promotes leanness and muscle growth in animals--is not safe for human or animal consumption and should not be used in food production. The U.S. approved the drug despite these concerns.
While representatives of the food industry were quick to praise the Trump administration's decision to place the Codex office under the watch of a former corporate executive, Michael Taylor, former deputy commissioner for foods at the Food and Drug Administration under former President Barack Obama, argued that the move had been undertaken with virtually no debate or discussion and that it "threatens the scientific credibility of the United States in Codex proceedings."
"There has been no dialogue on this proposal with the broad food safety community and no explanation from USDA of the problem the proposed reorganization solves," Taylor said.
The Trump administration's decision, Taylor concluded, could ultimately lower food safety standards, which would lead to "significant negative consequences in Africa and other developing regions."
In what critics are describing as a move to prioritize exports over public health, the Trump administration is quietly planning to transfer work on international food safety standards from the U.S. Department of Agriculture's (USDA) health arm to its brand new trade arm, which is supervised by former animal-drug industry executive Ted McKinney.
"There has been no dialogue on this proposal with the broad food safety community and no explanation from USDA of the problem the proposed reorganization solves."
--Michael Taylor, former FDA officialPolitico's Helena Bottemiller Evich first reported the "little-noticed" plan on Monday. Much of the concern "involves the USDA's staff that manages the U.S.' participation in the Codex Alimentarius Commission, a little-known but powerful standards-setting panel that sits under the U.N. Food and Agriculture Organization and the World Health Organization and is crucial for resolving trade disputes under the WTO," Bottemiller Evich notes.
The Codex Commission is currently debating whether to impose residue limits on the controversial drug zilpaterol, marketed as "beef-improvement technology" that is primarily used to promote growth in cattle.
Michael Hansen, a senior scientist at Consumers Union, told Politico that the Trump administration's decision to place McKinney--former global corporate affairs director of the animal pharmaceutical giant Elanco--in charge of what is often called "the food code" raises serious questions about "whether the U.S. will put even more pressure to make sure zilpaterol gets through."
The European Union, China, and other nations have insisted that zilpaterol--as well as ractopamine, a drug that promotes leanness and muscle growth in animals--is not safe for human or animal consumption and should not be used in food production. The U.S. approved the drug despite these concerns.
While representatives of the food industry were quick to praise the Trump administration's decision to place the Codex office under the watch of a former corporate executive, Michael Taylor, former deputy commissioner for foods at the Food and Drug Administration under former President Barack Obama, argued that the move had been undertaken with virtually no debate or discussion and that it "threatens the scientific credibility of the United States in Codex proceedings."
"There has been no dialogue on this proposal with the broad food safety community and no explanation from USDA of the problem the proposed reorganization solves," Taylor said.
The Trump administration's decision, Taylor concluded, could ultimately lower food safety standards, which would lead to "significant negative consequences in Africa and other developing regions."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.